Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://covid19.nih.gov/

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Name Principal Investigator Institution Study Date Approved Project ID
Implication of new models for predicting lung cancer screening selection based on CT scan and pathology image data Yuan Luo Northwestern University NLST Dec 31, 2020 NLST-745
Implication of new models for predicting lung cancer screening selection based on CT scan and pathology image data Yuan Luo Northwestern University PLCO Dec 31, 2020 PLCO-710
Validation of Deep Learning Algorithm on Nodule Detection using Chest Radiographs in the National Lung Screening Trial Hao Wu Infervision Medical Technology NLST Dec 29, 2020 NLST-744
Automated Medical Diagnostic Systems Fabien Scalzo University of California, Los Angeles (UCLA) PLCO Dec 29, 2020 PLCO-711
Multi-label Classification to Hierarchical Taxonomies for Lung cai chen Qingdao University of Science and Technology PLCO Dec 22, 2020 PLCOI-704
Development of improved pre-diagnostic biomarker-based screening algorithms for ovarian cancer Anna Lokshin UPMC Hillman Cancer Center PLCO Dec 22, 2020 2020-1020
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States. Haejin In Albert Einstein College of Medicine PLCO Dec 22, 2020 2020-1002
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States Xuehong Zhang Harvard Medical School and Brigham and Women's Hospital PLCO Dec 22, 2020 2020-1001
Convolutional Survival Machines: Deep Convolutional Networks for Survival Analysis with Time-Varying risks. Artur Dubrawski Carnegie Mellon University PLCO Dec 21, 2020 PLCOI-706
Diabetes, antidiabetic medication use, and the risk of ovarian cancer Susan Steck University of South Carolina PLCO Dec 21, 2020 PLCO-705
Artificial Intelligence To Predict The Risk Of Malignancy In Lung Cancer By Low-Dose CT Screening Studies Christian Salvatore DeepTrace Technologies, spin-off of University School for Advanced Studies IUSS Pavia NLST Dec 21, 2020 NLST-739
Convolutional Survival Machines: Deep Convolutional Networks for Survival Analysis with Time-Varying risks. Artur Dubrawski Carnegie Mellon University NLST Dec 21, 2020 NLST-738
Evaluation of a Lung Lesion Detection Tool Hajime Sasaki Hitachi Lyon Lab, Hitachi Medical Systems S.A.S. NLST Dec 18, 2020 NLST-736
Diabetes risk reduction diet and all-cause and cause-specific mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Dec 11, 2020 PLCO-700
Lung segmentation analysis tool Olivier Joly Brainomix NLST Dec 11, 2020 NLST-733
Dietary biomarker development in the Interactive Diet and Activity Tracking in AARP Study Erikka Loftfield National Cancer Institute IDATA Dec 11, 2020 2020-1014
Image Analysis of Lung CT Images Kevin Bowyer University of Notre Dame NLST Dec 8, 2020 NLST-731
Identifying risk factors associated with metastatic progression from non-metastatic primary lung cancer among NLST lung cancer patients Summer Han Stanford University NLST Dec 8, 2020 NLST-732
Genome-wide Association Study of Colorectal Cancer Using Penalized Orthogonal Components Regression Min Zhang Purdue University PLCO Dec 2, 2020 PLCO-697
HDoCS in PLCO: Health Disparities of Cancer Survivors in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Jacqueline Vo National Cancer Institute PLCO Dec 2, 2020 PLCO-696